|View printer-friendly version|
Dextera Surgical’s MicroCutter 5/80 Featured in Preclinical Laparoscopic Nephrectomy Study at SAGES Annual Meeting
“The results of the preclinical study show that the MicroCutter had
equivalent hemostasis to a conventional three-row surgical stapler in a
preclinical study of laparoscopic nephrectomy procedures,” said Dr.
Verdeja, associate professor of surgery and director, minimally invasive
In the poster, Dr. Verdeja presented results from 13 firings of the MicroCutter (5 millimeters in diameter) and 14 firings of a conventional three-row endostapler (12 millimeters in diameter). The study evaluated hemostasis (stopping of blood flow) and staple line quality when firing on the renal artery and renal vein as well as the ureter. Importantly, these firings demonstrate the MicroCutter’s performance on blood vessels with systemic pressures that come directly off the aorta and vena cava. After firing the stapler on these vessels, hypertension was induced for three minutes to further challenge hemostasis at the staple line.
The data demonstrate that there was no bleeding at any of the staple
lines from either the MicroCutter or the conventional endostapler at
initial firing or upon induction of hypertension. There were no adverse
events associated with either device. The data were presented at the
“Dr. Verdeja’s data confirm the excellent hemostasis results seen in
previous studies of the MicroCutter,” commented
MicroCutter Indication Information
The MicroCutter 5/80 Stapler and MicroCutter 30 Reloads are manufactured and cleared for use in the United States for transection and resection in multiple open or minimally invasive urologic, thoracic and pediatric surgical procedures, as well as application for transection, resection and/or creation of anastomoses in the small and large intestine, and the transection of the appendix. The MicroCutter 5/80 may be used with both MicroCutter 30 White Reloads in vascular/thin tissue and MicroCutter 30 Blue Reloads for standard tissue.
About Dextera Surgical
Dextera Surgical also markets the only automated anastomosis devices for coronary artery bypass graft (CABG) surgery on the market today: the C-Port® Distal Anastomosis Systems and PAS-Port® Proximal Anastomosis System. These products, sold by Dextera Surgical under the Cardica brand name, have demonstrated long-term reliable clinical performance for more than a decade.
The statements in this press release regarding Dextera Surgical’s
expectations as to the benefits of using the MicroCutter 5/80 in donor
nephrectomy procedures are "forward-looking statements." There are a
number of important factors that could cause Dextera Surgical’s results
to differ materially from those indicated by these forward-looking
statements, including the risks detailed from time to time in Dextera
Surgical’s reports filed with the
Dextera Surgical Inc.